Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från BioStock via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2025-09-22 13:43:00
Europe is facing a growing threat from Candidozyma auris, a hospital-spreading fungus resistant to many treatments. The European Centre for Disease Prevention and Control (ECDC) recently released a report confirming a sharp rise in cases and warning that transmission has become endemic in several countries. We asked Biosergen CEO Tine Olesen what this means for the company’s ongoing development of antifungal candidate BSG005.
Read the full interview at biostock.se:
ECDC raises alarm about C. auris – Biosergen wants to contribute to the solution
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/